Listings

In this section

Excellence Awards

Buyer's Guides

12/20/2024 11:15:12
  • Home | US reproductive laws could limit women’s participation in clinical trials
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Avenga Company Insight
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Interphex
  • Investment and Development Agency of Latvia Company Insight
  • In Depth
  • US reproductive laws could limit women’s participation in clinical trials
  • How Pfizer management outplayed activist investor Starboard
  • Trump 2.0 spells global change in pharmaceutical regulation, funding and investment
  • Flu vaccine strategy on the line as new US leaders anticipated to take charge
  • Lilly’s £279m bet aims to boost UK life sciences sector
  • PrEP therapies offer new hope in HIV preventive landscape as vaccine failures amass
  • Datwyler
  • Pharma Event Guide
  • In this guide
  • Avenga Company Insight
  • AST Company Insight
  • ICROM Company Insight
  • Girteka Company Insight
  • 2024 Event Highlights
  • Swiss biotech ecosystem recuperates from global financial instability
  • Cell and gene therapy approvals drive paradigm change in manufacturing
  • Will the tide turn for the wave of pharma layoffs?
  • AIDS 24: Prioritise at risk populations for trials, testing and treatment
  • Pharma readies for climate disasters amidst supply chain concerns
  • Amgen showcases exciting potential in the obesity space at JPM24
  • Experts call for a shift from reactive to proactive clinical trial supply frameworks
  • 2025 Event Calendar
  • Interphex
  • Advertise with us
  • Listings
  • Pharmaceutical Technology Excellence Awards 2024 winners
  • Buyer's Guides
  • Next issue
12/19/2024 00:00:00